Tolerability of 2.5% Lidocaine/Prilocaine Hydrogel in Children Undergoing Cryotherapy for Molluscum Contagiosum.

Authors :: Gobbato AA
Babadópulos T
Gobbato CA
Moreno RA
Gagliano-Jucá T
De Nucci G
Source :: Pediatric dermatology [Pediatr Dermatol] 2016 May; Vol. 33 (3), pp. e214-5. Date of Electronic Publication: 2016 Apr 04.
Publication Year :: 2016
Abstract: The tolerability of a 2.5% lidocaine/prilocaine hydrogel (Nanorap, Biolab Indústria Farmacêutica Ltd., Sao Paulo, Brazil) was evaluated in 20 children ages 2 to 11 years undergoing cryotherapy for molluscum contagiosum (MC). The product was well tolerated, with only two children presenting with eczema at the application site. These adverse reactions were considered unlikely to be related to the test product, because a patch test was negative in one of the individuals and the other event occurred in only one of the two treated areas. Nanorap is an efficacious and well-tolerated option for topical anesthesia in children undergoing cryotherapy for MC.<br /> (© 2016 Wiley Periodicals, Inc.)

Subjects :: Child
Child, Preschool
Cryotherapy methods
Drug Combinations
Female
Humans
Hydrogel, Polyethylene Glycol Dimethacrylate
Lidocaine therapeutic use
Male
Pain etiology
Pain Measurement
Prilocaine therapeutic use
Treatment Outcome
Anesthetics, Local therapeutic use
Cryotherapy adverse effects
Drug Tolerance
Molluscum Contagiosum diagnosis
Molluscum Contagiosum therapy
Pain prevention & control

Full Text Access

Tools